Deep Tech Startups

Airhive develops low-cost direct air capture (DAC) technology using fluidised beds, a mineral sorbent, and an electric calciner to remove CO2 from ambient air. It supplies carbon removal credits, CO2 for industrial uses such as beverage carbonation and sustainable aviation fuel, and modular DAC units and technology licensing, with large-scale deployment planned in the UK.

3 investors

Akhetonics develops all-optical computing hardware based on photonic integrated circuits that generate nonlinear optical operations, enabling optical logic gates, analog mathematical operations, optical memory, and quantum feed-forward. Its cross-domain architecture combines digital, analog, and quantum optical processing into XPUs aimed at low-power, high-performance compute for edge deployment outside the data center.

3 investors

Alamar Biosciences develops NULISA, an ultra-high-sensitivity, high-specificity technology for analyzing hundreds of protein biomarkers from small biofluid samples, building on the team's prior spatial genomics work (RNAscope). The company serves proteomics research and clinical drug development applications.

3 investors

Alba Orbital manufactures PocketQube satellites and operates as a launch broker, providing small satellite deployment services. The company also operates nighttime imaging satellites and ground station services for government and commercial clients in the space sector.

3 investors

Albotherm develops a heat-activated coating for adaptive glazing that changes transparency in response to temperature, validated in commercial greenhouse trials and in development for the built environment, energy, and mobility surfaces. It targets horticulture growers, commercial building glazing, and PV/vehicle applications as a passive alternative to chalk shade paint and electrochromic or motorised systems.

3 investors

Alchemy develops vertically integrated nanotechnology solutions for high-value applications across various industries. The company focuses on fundamental nanotechnology innovations to solve major problems and delivers ready-to-use end products rather than components.

3 investors

Alchemy provides a Product Development Platform including electronic lab notebooks, laboratory information management systems, and artificial intelligence tools that help chemists and material scientists accelerate research, product development, and quality control. The platform integrates with CRM, ERP, and lab equipment systems to digitize core lab processes and improve throughput.

3 investors

Aldoria develops space surveillance technology for Space Situational Awareness (SSA) and Space Traffic Management (STM), serving governments, space agencies, institutions, and commercial satellite operators. The company uses ITAR-free technologies to provide orbital risk management, asset protection, and traffic coordination, with a focus on European space autonomy.

3 investors

Aledia develops next-generation MicroLED display technology based on 3D nanowires grown on silicon, operating a pilot line and high-volume production facility. It manufactures MicroLED semiconductor solutions from its production site near Grenoble, France.

3 investors

AlensiaXR develops holographic technology that replaces traditional cadavers in medical and dental education. The company serves medical schools, dental schools, and other health professions institutions seeking immersive, accessible anatomical learning experiences.

3 investors

Alice & Bob develops quantum computing hardware based on the cat qubit, a qubit design with built-in error correction, and offers Helium, a testbed for error correction. The company aims to build a universal, fault-tolerant quantum computer for high performance computing applications.

3 investors

AlixLabs develops Atomic Layer Etch (ALE) equipment for semiconductor manufacturing, including its Atomic Pitch Splitting (APS) technology that replaces multiple patterning steps with a single process to lower the cost of producing leading-edge chips. The company positions itself as a pure-play ALE hardware maker for advanced chip production in Europe.

3 investors

Allfocal Optics develops nanophotonic display technology based on research from Cambridge University, aimed at improving visual clarity and comfort. Its displays are designed to be more accessible to users, including people with vision impairments such as myopia, hyperopia, and astigmatism.

3 investors

A venture studio embedded within Alloy Therapeutics that partners with academics, entrepreneurs, pharma companies, and VCs to create and develop early-stage drug discovery companies. It gives its portfolio companies access to Alloy's discovery technologies and enabling services, and support in strategy, legal, R&D funding, and partnerships to reach Series A financing.

3 investors

Allozymes develops custom enzymes using high-throughput experimentation combined with AI-guided design for enzyme engineering and biocatalysis. It applies these engineered enzymes to industrial and scientific applications.

3 investors

Alsemy builds AI-driven platforms that generate neural network-based device compact models and optimize semiconductor design and manufacturing through process modeling, simulation, and DTCO. Its products (Alsis, Alsphere, Alscope) serve the semiconductor industry to accelerate chip modeling and reduce process bottlenecks.

3 investors

Alta develops mining technology aimed at securing critical mineral supply chains, based on technology licensed from Lawrence Livermore National Laboratory and co-developed with researchers at Pennsylvania State University. The company focuses on strengthening U.S. competitiveness in critical mineral production.

3 investors

Altos Labs develops computational and scientific approaches to reverse disease through breakthrough medicines, operating research institutes focused on cell health, computation, and drug discovery.

3 investors

Amber Bio is a biotechnology company developing a novel RNA writing platform capable of multi-kilobase gene edits that can treat multiple mutations across patients with a single product.

3 investors

Amperesand manufactures medium voltage solid-state transformers for critical power infrastructure, enabling faster deployment of power systems for AI data centers and industrial applications. The company's factory-built platform consolidates multiple electrical components to reduce installation time and space requirements.

3 investors

AMPLY Discovery is a UK-based biotech company that uses AI and computational biology to identify therapeutic targets in non-coding regions of the genome and develop first-in-class drugs through an integrated discovery platform combining machine learning with wet-lab validation. The company is developing therapeutics for oncology and drug-resistant infectious diseases, particularly antimicrobial-peptide and long non-coding RNA oligonucleotide programmes.

3 investors

Andon Labs develops safety systems and protocols for autonomous AI-driven organizations, focusing on AI alignment and control mechanisms for agents that operate without human oversight.

3 investors

Ångström AI develops AI-powered physics simulations for pharmaceutical drug discovery, computing molecular properties like solubility, lipophilicity, and crystal structure stability to replace traditional lab experiments. The platform uses machine learning interatomic potentials and free energy calculations to accelerate and derisk solid form development for pharma companies.

3 investors

Amadeus Capital Partners is a UK venture capital firm, founded in 1997, that invests in deep technology companies from seed to growth stage across three areas: Intelligence (AI, advanced computing, quantum), Human (health, medicine, wellness), and Planet (sustainability, energy, materials, space). It has backed more than 200 companies and raised over $1.3 billion for investment.

3 investors